{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:09:52Z","timestamp":1780607392610,"version":"3.54.1"},"reference-count":16,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T00:00:00Z","timestamp":1100736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A 43\u2010year\u2010old patient developed factor V inhibitor 6 months after liver transplantation for primary biliary cirrhosis in association with Sj\u00f6gren's syndrome\/systemic lupus erythematosus. She suffered from ecchymoses in the lower extremities. The factor V inhibitor was eradicated after 10 weekly doses of 375\u2013500 mg\/m<jats:sup>2<\/jats:sup> rituximab. Am. J. Hematol. 77:363\u2013365, 2004. \u00a9 2004 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.20181","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T21:51:59Z","timestamp":1100814719000},"page":"363-365","source":"Crossref","is-referenced-by-count":28,"title":["Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis"],"prefix":"10.1002","volume":"77","author":[{"given":"Eric Chun\u2010Yet","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas G.","family":"Tzakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,11,18]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(98)80050-4"},{"issue":"3","key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2141.1993.tb03343.x","article-title":"Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V","volume":"85","author":"Banninger H","year":"1993","journal-title":"Br J Haematol"},{"issue":"4","key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0609.1975.tb02428.x","article-title":"A circulating factor V inhibitor: possible side effect of treatment with streptomycin","author":"Stenbjerg S","year":"1975","journal-title":"Scand J Haematol"},{"issue":"5","key":"e_1_2_1_5_2","first-page":"357","article-title":"An acquired factor V inhibitor: clinical and laboratory features","volume":"30","author":"Shastri KA","year":"1999","journal-title":"J Med"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199910150-00026"},{"issue":"2","key":"e_1_2_1_7_2","first-page":"165","article-title":"Acquired circulating anticoagulant with anti\u2010factor V activity in AIDS: first case report","volume":"37","author":"Denis A","year":"1995","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10172"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00063-003-1268-7"},{"issue":"4","key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1365-2141.1995.tb08430.x","article-title":"Factor V inhibitor associated with Sj\u00f6gren's syndrome","volume":"89","author":"Koyama T","year":"1995","journal-title":"Br J Haematol"},{"issue":"5","key":"e_1_2_1_11_2","first-page":"303","article-title":"Inhibitor to factor V in severe factor V congenital deficiency. A case report","volume":"27","author":"Mazzucconi MG","year":"1985","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.3985"},{"issue":"5","key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V56.5.835.835","article-title":"Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions","volume":"56","author":"Chediak J","year":"1980","journal-title":"Blood"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199705000-00009"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0765"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2002.02686.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.2002.0522"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.20181","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.20181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T22:04:27Z","timestamp":1700172267000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.20181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,18]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1002\/ajh.20181"],"URL":"https:\/\/doi.org\/10.1002\/ajh.20181","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,18]]}}}